High-risk Diffuse Large B-Cell Lymphoma
Also known as: High-risk Diffuse Large B-Cell Lymphoma (DLBCL)
| Drug | Drug Name | Drug Description |
|---|
| Drug | Drug Name | Target | Type |
|---|
| Drug | Drug Name | Phase | Status | Count |
|---|---|---|---|---|
| DB09052 | Blinatumomab | 2 | Completed | 1 |
| DB09052 | Blinatumomab | 2 | Terminated | 1 |
| DB01234 | Dexamethasone | 2 | Completed | 1 |